{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:08:11Z","timestamp":1788232091588,"version":"build-2803163510"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Chronic kidney disease (CKD) has a major impact on public health, which could progress to end-stage kidney disease (ESRD) and consume many medical resources. Currently, the treatment for CKD has many flaws, so more effective treatment tools are urgently required for CKD. Mesenchymal stem cells (MSCs) are primitive cells with self-renewal and proliferation capacity and differentiation potential. Extensive preclinical and clinical data has shown that cell-based therapies using MSCs can modulate immunity, inhibit inflammatory factors, and improve renal function in CKD, suggesting that MSCs have the potential to be a new, effective therapeutic tool for CKD. In this review, we will describe different kinds of MSCs and MSCs products for the treatment of CKD in experimental models and clinical trials, potential signaling pathways, therapeutic efficacy, and critical issues that need to be addressed before therapeutic application in humans.<\/jats:p>","DOI":"10.3389\/fcell.2022.910592","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T10:20:49Z","timestamp":1664878849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Jiali","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongda","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiutian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/jcp.29004","article-title":"Human umbilical cord mesenchymal stem cell\u2010derived extracellular vesicles: A novel therapeutic paradigm","volume":"235","author":"Abbaszadeh","year":"2020","journal-title":"J. Cell. Physiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1089\/ten.TEA.2011.0391","article-title":"Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers","volume":"18","author":"Aguado","year":"2012","journal-title":"Tissue Eng. Part A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/cjn.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13287-016-0386-0","article-title":"Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats","volume":"7","author":"Ashour","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12015-015-9587-7","article-title":"Stem cell-based therapy in idiopathic pulmonary fibrosis","volume":"11","author":"Barczyk","year":"2015","journal-title":"Stem Cell Rev Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.24272\/j.issn.2095-8137.2017.055","article-title":"Kidney disease models: tools to identify mechanisms and potential therapeutic targets","volume":"39","author":"Bao","year":"2018","journal-title":"Zool. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"30481","DOI":"10.1074\/jbc.M500573200","article-title":"Extracellular matrix proteoglycans control the fate of bone marrow stromal cells","volume":"280","author":"Bi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12015-011-9345-4","article-title":"Multipotent mesenchymal stromal cell therapy and risk of malignancies","volume":"9","author":"Casiraghi","year":"2013","journal-title":"Stem Cell Rev Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/sci-2020-026","article-title":"Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy","volume":"8","author":"Chin","year":"2021","journal-title":"Stem Cell Investig."},{"key":"B9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/14653249.2011.574118","article-title":"Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy","volume":"13","author":"Chin","year":"2011","journal-title":"Cytotherapy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/14653240903313966","article-title":"Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy","volume":"12","author":"Chin","year":"2010","journal-title":"Cytotherapy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3727\/096368915X687534","article-title":"Bone marrow-derived mesenchymal stem cells and their conditioned medium attenuate fibrosis in an irreversible model of unilateral ureteral obstruction","volume":"24","author":"Da Silva","year":"2015","journal-title":"Cell Transpl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","article-title":"A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis","volume":"76","author":"Deng","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"F4","DOI":"10.1152\/ajprenal.00045.2005","article-title":"Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction","volume":"290","author":"Docherty","year":"2006","journal-title":"Am. J. Physiology-Renal Physiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Int. Soc. Cell. Ther. position statementCytotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2016.54","article-title":"Developmental signalling pathways in renal fibrosis: The roles of Notch, Wnt and hedgehog","volume":"12","author":"Edeling","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-kddc): A cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","article-title":"Mesenchymal stem cell therapy for liver fibrosis","volume":"30","author":"Eom","year":"2015","journal-title":"Korean J. Intern Med."},{"key":"B18","first-page":"3","article-title":"Erythropoietin 1991--an overview","volume":"18","author":"Eschbach","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","article-title":"Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice","volume":"14","author":"Ezquer","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-016-0383-3","article-title":"Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues","volume":"7","author":"Fazzina","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coche.2016.11.003","article-title":"The diverse roles of hydrogel mechanics in injectable stem cell transplantation","volume":"15","author":"Foster","year":"2017","journal-title":"Curr. Opin. Chem. Eng."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3727\/096368914x684619","article-title":"Mesenchymal stromal cells improve renovascular function in polycystic kidney disease","volume":"24","author":"Franchi","year":"2015","journal-title":"Cell Transpl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/214074","article-title":"Cellular stress responses: Cell survival and cell death","volume":"2010","author":"Fulda","year":"2010","journal-title":"Int. J. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1755.2002.00350.x","article-title":"Hyperkalemia: An adaptive response in chronic renal insufficiency","volume":"62","author":"Gennari","year":"2002","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-7-4","article-title":"The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis?","volume":"7","author":"Genovese","year":"2014","journal-title":"Fibrogenes. Tissue Repair"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41598-019-41100-9","article-title":"Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy","volume":"9","author":"Grange","year":"2019","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e12535","DOI":"10.1111\/jpi.12535","article-title":"Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrPC -dependent enhancement of the mitochondrial function","volume":"66","author":"Han","year":"2019","journal-title":"J. Pineal Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2015.06.070","article-title":"Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model","volume":"198","author":"Han","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/srep10902","article-title":"Extracellular matrix can recover the downregulation of adhesion molecules after cell detachment and enhance endothelial cell engraftment","volume":"5","author":"He","year":"2015","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","article-title":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors","volume":"94","author":"Heerspink","year":"2018","journal-title":"Kidney Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fimmu.2015.00465","article-title":"Animal models to study links between cardiovascular disease and renal failure and their relevance to human pathology","volume":"6","author":"Hewitson","year":"2015","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chemico-Biological Interact."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8814574","article-title":"Comparison of the effects of mesenchymal stem cells with their extracellular vesicles on the treatment of kidney damage induced by chronic renal artery stenosis","volume":"2020","author":"Ishiy","year":"2020","journal-title":"Stem Cells Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1677\/joe-10-0305","article-title":"Superoxide induced by a high-glucose concentration attenuates production of angiogenic growth factors in hypoxic mouse mesenchymal stem cells","volume":"208","author":"Ishizuka","year":"2011","journal-title":"J. Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-020-01633-7","article-title":"Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2","volume":"11","author":"Jin","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3727\/096368912x655019","article-title":"Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats","volume":"22","author":"Katsuno","year":"2013","journal-title":"Cell Transpl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fcell.2020.00188","article-title":"Mesenchymal stem cell derived extracellular vesicles ameliorate kidney injury in aristolochic acid nephropathy","volume":"8","author":"Kholia","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1359\/jbmr.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J. Bone Min. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00418-008-0519-3","article-title":"Isolation and characterization of oct-4+\/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers","volume":"131","author":"La Rocca","year":"2009","journal-title":"Histochem Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","article-title":"The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease","volume":"59","author":"Lager","year":"2001","journal-title":"Kidney Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"722365","DOI":"10.3389\/fcell.2021.722365","article-title":"Melatonin promotes the therapeutic effect of mesenchymal stem cells on type 2 diabetes mellitus by regulating TGF-\u03b2 pathway","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","article-title":"Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation","volume":"34","author":"Li","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study","volume":"69","author":"Liang","year":"2010","journal-title":"Ann. Rheumatic Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/nep.13099","article-title":"Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction","volume":"23","author":"Liu","year":"2018","journal-title":"Nephrology"},{"key":"B46","first-page":"3921","article-title":"Erratum: Exosomes released by human umbilical cord mesenchymal stem cells protect against renal interstitial fibrosis through ROS-mediated P38MAPK\/ERK signaling pathway","volume":"13","author":"Liu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9370919","article-title":"Xenogeneic transplantation of human placenta-derived mesenchymal stem cells alleviates renal injury and reduces inflammation in a mouse model of lupus nephritis","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13287-017-0557-7","article-title":"Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients","volume":"8","author":"Makhlough","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2014.08.002","article-title":"Lupus nephritis: Animal modeling of a complex disease syndrome pathology","volume":"11","author":"McGaha","year":"2014","journal-title":"Drug Discov. Today Dis. Models"},{"key":"B51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5966\/sctm.2012-0184","article-title":"Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts","volume":"2","author":"Melief","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e041404","DOI":"10.1136\/bmjopen-2020-041404","article-title":"Comparison of health literacy profile of patients with end-stage kidney disease on dialysis versus non-dialysis chronic kidney disease and the influencing factors: A cross-sectional study","volume":"10","author":"Murali","year":"2020","journal-title":"BMJ Open"},{"key":"B53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transpl."},{"key":"B54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.ki.5001521","article-title":"Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice","volume":"70","author":"Ninichuk","year":"2006","journal-title":"Kidney Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","article-title":"Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: A randomized, placebo-controlled, dose escalation study","volume":"12","author":"Packham","year":"2016","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","article-title":"Advances in the pathogenesis and treatment of polycystic kidney disease","volume":"18","author":"Patel","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B57","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00000542-199003000-00031","article-title":"Percutaneous extracorporeal CO2 removal in a patient with bullous emphysema with recurrent bilateral pneumothoraces and respiratory failure","volume":"72","author":"Pesenti","year":"1990","journal-title":"Anesthesiology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ki.1981.22","article-title":"Sexual dysfunction in the male patient with uremia: A reappraisal","volume":"19","author":"Procci","year":"1981","journal-title":"Kidney Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br. J. Haematol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1098612X15576980","article-title":"Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: A randomized, placebo-controlled clinical trial in eight cats","volume":"18","author":"Quimby","year":"2016","journal-title":"J. Feline Med. Surg."},{"key":"B62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fcell.2020.00296","article-title":"Nephroprotective potential of mesenchymal stromal cells and their extracellular vesicles in a murine model of chronic cyclosporine nephrotoxicity","volume":"8","author":"Ram\u00edrez-Bajo","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: Results of a phase I study","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5661\/bger-26-163","article-title":"Supply of nutrients to cells in engineered tissues","volume":"26","author":"Rouwkema","year":"2009","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/530501","article-title":"Transplanted human umbilical cord mesenchymal stem cells facilitate lesion repair in B6.Fas mice","volume":"2014","author":"Ruan","year":"2014","journal-title":"J. Immunol. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10735-019-09812-4","article-title":"Melatonin preconditioning of bone marrow-derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease","volume":"50","author":"Saberi","year":"2019","journal-title":"J. Mol. Hist."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1634\/stemcells.2008-0512","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells","volume":"26","author":"Secchiero","year":"2008","journal-title":"Stem Cells"},{"key":"B68","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1302\/0301-620x.77b1.7822372","article-title":"Human bone-cell proliferation in vitro decreases with human donor age","author":"Shigeno","year":"1995","journal-title":"J. Bone Jt. Surg. Br. volume"},{"key":"B69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40620-020-00733-0","article-title":"Atherosclerotic-nephropathy: An updated narrative review","volume":"34","author":"Simeoni","year":"2021","journal-title":"J. Nephrol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ki.1996.444","article-title":"Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis","volume":"50","author":"Stefanski","year":"1996","journal-title":"Kidney Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/ndt\/gfs260","article-title":"The pathogenic role of the renal proximal tubular cell in diabetic nephropathy","volume":"27","author":"Tang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"B72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.leukres.2015.10.004","article-title":"Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth","volume":"40","author":"Teoh","year":"2016","journal-title":"Leukemia Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1590\/s0102-8650201400160005","article-title":"Animal model of chronic kidney disease using a unilateral technique of renal ischemia and reperfusion in White New Zealand rabbits","volume":"29","author":"Togoe","year":"2014","journal-title":"Acta Cir. Bras."},{"key":"B74","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ki.1995.79","article-title":"A re-evaluation of the urinary parameters of acid production and excretion in patients with chronic renal acidosis","volume":"47","author":"Uribarri","year":"1995","journal-title":"Kidney Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/cs20120644","article-title":"Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure","volume":"125","author":"Villanueva","year":"2013","journal-title":"Clin. Sci. (Lond)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Ijms"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/mt.2016.90","article-title":"Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","article-title":"A long-term follow-up study of allogeneic mesenchymal stem\/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus","volume":"10","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/s0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4252\/wjsc.v13.i7.914","article-title":"Current advances of stem cell-based therapy for kidney diseases","volume":"13","author":"Wong","year":"2021","journal-title":"Wjsc"},{"key":"B81","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/cbin.10231","article-title":"In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells","volume":"38","author":"Wong","year":"2014","journal-title":"Cell Biol. Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e90883","DOI":"10.1371\/journal.pone.0090883","article-title":"Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1002\/jcb.28254","article-title":"Bone marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model","volume":"120","author":"Xing","year":"2019","journal-title":"J Cell. Biochem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"key":"B87","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","article-title":"Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies","volume":"33","author":"Zhang","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/stem.1263","article-title":"Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms","volume":"31","author":"Zhu","year":"2013","journal-title":"Stem Cells"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.910592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T10:20:55Z","timestamp":1664878855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.910592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":89,"alternative-id":["10.3389\/fcell.2022.910592"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.910592","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"910592"}}